Osaic Holdings’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-87
Closed -$61 – 7516
2023
Q4
$61 Hold
87
– – ﹤0.01% 7153
2023
Q3
$60 Hold
87
– – ﹤0.01% 7265
2023
Q2
$210 Sell
87
-1
-1% -$4 ﹤0.01% 7198
2023
Q1
$718 Sell
88
-2
-2% -$27 ﹤0.01% 7057
2022
Q4
$1K Sell
90
-56
-38% -$640 ﹤0.01% 7024
2022
Q3
$2K Hold
146
– – ﹤0.01% 6879
2022
Q2
$5K Sell
146
-35
-19% -$1.09K ﹤0.01% 6522
2022
Q1
$7K Hold
181
– – ﹤0.01% 6359
2021
Q4
$8K Buy
181
+14
+8% +$873 ﹤0.01% 6428
2021
Q3
$11K Buy
167
+36
+27% +$2.63K ﹤0.01% 6163
2021
Q2
$10K Buy
131
+57
+77% +$3.47K ﹤0.01% 6094
2021
Q1
$5K Sell
74
-128
-63% -$10K ﹤0.01% 6198
2020
Q4
$7K Buy
202
+127
+169% +$5.65K ﹤0.01% 5679
2020
Q3
$4K Sell
75
-42
-36% -$2.49K ﹤0.01% 5676
2020
Q2
$4K Hold
117
– – ﹤0.01% 5601
2020
Q1
$3K Buy
+117
New +$4.96K ﹤0.01% 5601

Other funds holding DMK

Osaic Holdings's DMK Position: Q1 2024 in Review

Osaic Holdings sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 87 shares — an estimated $61 sold.

Osaic Holdings first reported a position in DMK in Q1 2020 and held it in 16 quarters. The position peaked at $11K in Q3 2021. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Osaic Holdings reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 87 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $61.
  • Osaic Holdings first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's DMK Pharmaceuticals Corporation Common Stock position peaked at $11K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.